Author | John Carreyrou |
---|---|
Subject | Theranos |
Published | May 21, 2018 |
Publisher | Alfred A. Knopf |
ISBN | 978-1-5247-3165-6 |
OCLC | 1029779381 |
338.7/681761 | |
LC Class | HD9995.H423 U627 2018 |
Bad Blood: Secrets and Lies in a Silicon Valley Startup is a nonfiction book by journalist John Carreyrou, released May 21, 2018. It covers the rise and fall of Theranos, the multibillion-dollar biotech startup headed by Elizabeth Holmes. [1] The book received critical acclaim, winning the 2018 Financial Times and McKinsey Business Book of the Year Award.
In 2021, a film adaptation was announced, to star Jennifer Lawrence, to be written by Vanessa Taylor and to be directed by Adam McKay. [2] However, after seeing Amanda Seyfried's critically acclaimed performance playing Holmes in the limited series The Dropout , Lawrence exited the project. [3]
In late 2015, Carreyrou began a series of investigative articles on Theranos, published in The Wall Street Journal on the blood-testing startup founded by Elizabeth Holmes. The articles questioned the company's claim to be able to run a wide range of lab tests from a tiny sample of blood from a finger prick. [4] [5] [6] In May 2018 Bad Blood: Secrets and Lies in a Silicon Valley Startup was published by Knopf.
In 2021, Carreyrou released a podcast called "Bad Blood: The Final Chapter" covering the trial of Elizabeth Holmes. [7]
While Roger Lowenstein from The New York Times conceded that "Carreyrou's presentation has a few minor flaws"—such as an excessive number of characters and occasional reliance on stereotypes—he concluded that "such blemishes in no way detract from the power of Bad Blood", and that "the author compellingly relates how he got involved" and "is admirably frank about his craft". He added, "The author's description of Holmes as a manic leader who turned coolly hostile when challenged is ripe material for a psychologist; Carreyrou wisely lets the evidence speak for itself." [1] Kevin Nguyen with GQ magazine likewise called "Carreyrou’s reporting ... exhaustive, including interviews with more than 150 people", and said "the book stumbles a bit in its third act, when Carreyrou introduces himself and how he broke the story". However, he continued by saying that "these are small issues in a book that speaks volumes to tech at large", and that, "Bad Blood is a satisfying read for anyone who wants a book full of salacious startupenfreude." [8]
Charles Harry with the Library Journal said "Carreyrou's clearly written and accessible work can be compared to another outstanding business exposé, James B. Stewart’s Den of Thieves ," and "highly recommended for all collections". [9] Danny Crichton, with TechCrunch, said "Carreyrou's tenacious and intrepid reporting at The Wall Street Journal would ultimately expose one of the largest frauds ever perpetrated in Silicon Valley ... And yet, what I found in the book was not all that thrilling or shocking, but rather astonishingly pedestrian." He explained, "Carreyrou's laconic WSJ tone, with its 'just the facts' attitude ... is punctuated only occasionally by brief interludes on the motivations and psychology of its characters", and that it "lacks the sort of verve that makes business thrillers like Barbarians at the Gate or Red Notice so engaging". [10]
Bill Gates said: "Bad Blood tackles some serious ethical questions, but it is ultimately a thriller with a tragic ending. It's a fun read full of bizarre details that will make you gasp out loud." [11]
The book was included on end-of-year lists, including the New York Post 's list of the 28 most unforgettable books of 2018, [12] NPR's Guide To 2018's Great Reads, [13] and The New York Times Book Review 's 100 Notable Books of 2018. [14] The book also won the 2018 Financial Times and McKinsey Business Book of the Year Award. [15] [16]
David Boies is an American lawyer and chairman of the law firm Boies Schiller Flexner LLP. Boies rose to national prominence for three major cases: leading the U.S. federal government's successful prosecution of Microsoft in United States v. Microsoft Corp., his unsuccessful representation of Democratic presidential candidate Al Gore in Bush v. Gore, and for successful representation of the plaintiff in Hollingsworth v. Perry, which invalidated California Proposition 8 banning same-sex marriage. Boies has also represented various clients in US lawsuits, including Theranos, tobacco companies, Harvey Weinstein, and Jeffrey Epstein's victims including Virginia Roberts Giuffre.
Avadis "Avie" Tevanian is an American software engineer. At Carnegie Mellon University, he was a principal designer and engineer of the Mach operating system. He used that work at NeXT Inc. as the foundation of the NeXTSTEP operating system. He was senior vice president of software engineering at Apple from 1997 to 2003, and then chief software technology officer from 2003 to 2006. There, he redesigned NeXTSTEP to become macOS. Apple's macOS and iOS both incorporate the Mach Kernel, and iPadOS, watchOS, and tvOS are all derived from iOS. He was a longtime friend of Steve Jobs.
Bad Blood may refer to:
Gary Roughead is a former United States Navy officer who served as the 29th Chief of Naval Operations from 2007 to 2011. He previously served as Commander, United States Fleet Forces Command from May 17 to September 29, 2007. Prior to that, Roughead served as the 31st Commander, United States Pacific Fleet from 2005 to 2007. In 2011, he retired from the U.S. Navy after 38 years of service.
Charles Louis Fleischmann was a Jewish Hungarian-American manufacturer of yeast who founded Fleischmann Yeast Company.
Boies Schiller Flexner LLP is an American law firm based in New York City. The firm was founded by David Boies and Jonathan D. Schiller, in 1997, who, in 1999, were joined by Donald L. Flexner, former partner with Crowell & Moring, then forming Boies, Schiller & Flexner.
Theranos Inc. was an American privately held corporation that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $10 billion valuation at its peak in 2013 and 2014. The company claimed that it had devised blood tests that required very small amounts of blood and that could be performed rapidly and accurately, all using compact automated devices that the company had developed. These claims were proven to be false.
Elizabeth Anne Holmes is an American biotechnology entrepreneur who was convicted of fraud in connection to her blood-testing company, Theranos. The company's valuation soared after it claimed to have revolutionized blood testing by developing methods that needed only very small volumes of blood, such as from a fingerprick. In 2015, Forbes had named Holmes the youngest and wealthiest self-made female billionaire in the United States on the basis of a $9-billion valuation of her company. In the following year, as revelations of fraud about Theranos's claims began to surface, Forbes revised its estimate of Holmes's net worth to zero, and Fortune named her in its feature article on "The World's 19 Most Disappointing Leaders".
Noble cause corruption is corruption caused by the adherence to a teleological ethical system, suggesting that people will use unethical or illegal means to attain desirable goals, a result which appears to benefit the greater good. Where traditional corruption is defined by personal gain, noble cause corruption forms when someone is convinced of their righteousness, and will do anything within their powers to achieve the desired result. An example of noble cause corruption is police misconduct "committed in the name of good ends" or neglect of due process through "a moral commitment to make the world a safer place to live." The knowing misconduct by a law enforcement officer or prosecutor with the goal of attaining what the officer believes is a "just" result.
Joseph Fuisz is an American attorney, inventor, and entrepreneur of Slovenian descent. He works predominantly in the pharmaceutical industry as the founder of Fuisz Pharma LLC. As of October 2015, he is named on 32 medical patents, and over forty patents.
John Carreyrou is a French-American investigative reporter at The New York Times. Carreyrou worked for The Wall Street Journal for 20 years between 1999 and 2019 and has been based in Brussels, Paris, and New York City. He won the Pulitzer Prize twice and helped expose the fraudulent practices of the multibillion-dollar blood-testing company Theranos in a series of articles published in The Wall Street Journal.
Ramesh "Sunny" Balwani is a businessman, former president and chief operating officer of Theranos, which was a privately held health technology company founded by his then-girlfriend Elizabeth Holmes. He and Holmes fraudulently represented that they had devised a revolutionary blood test that required only small amounts of blood, such as from a fingerstick. Both Balwani and Holmes were convicted of fraud. The consequences of the fraud led to the collapse of Theranos and the loss of billions of dollars to investors.
Ian Gibbons was a British biochemist and molecular biology researcher who served as the chief scientist of the US company Theranos, which was founded by Elizabeth Holmes. For more than 30 years, Gibbons performed research in medical therapeutics and diagnostic testing prior to joining Theranos in 2005. He attempted to raise issues with Theranos' management about the inaccuracy of their testing devices.
The Inventor: Out for Blood in Silicon Valley is a 2019 American documentary film, directed and produced by Alex Gibney. The film revolves around Elizabeth Holmes and her former company Theranos. It is considered a companion piece to the book, Bad Blood: Secrets and Lies in a Silicon Valley Startup.
Roger Harris Parloff is an American journalist who formerly worked at Fortune and currently is a senior editor at Lawfare.
The Dropout is an American biographical drama television miniseries that dramatizes the rise and fall of the disgraced biotechnology company Theranos and its founder, Elizabeth Holmes, played by Amanda Seyfried. It features an ensemble supporting cast, including Naveen Andrews, Elizabeth Marvel, William H. Macy, Stephen Fry, Mary Lynn Rajskub, Bill Irwin, Utkarsh Ambudkar, LisaGay Hamilton, Michael Ironside, Laurie Metcalf, Anne Archer, and Sam Waterston. Created by Elizabeth Meriwether, the series is based on the podcast of the same name hosted by Rebecca Jarvis and produced by ABC News.
Channing Rex Robertson is a professor emeritus of chemical engineering at Stanford University. He held multiple significant roles at startup Theranos, founded by his student Elizabeth Holmes. Robertson took on major responsibilities at the company prior to its collapse, including becoming its first board member, engaging with venture capitalists, and recruiting biochemist Ian Gibbons. He retired from Stanford in 2012, becoming professor emeritus. Theranos named him the co-leader of their technology advisory board in 2017. He was called as a witness in United States v. Elizabeth A. Holmes, et al., which convicted Holmes and partner Sunny Balwani of criminal fraud. During his time working for Holmes, Robertson was paid US$500,000 per year by Theranos. Since his active role in the Theranos scandal, he went back to teach one course at Stanford.
Phyllis I. Gardner is a Professor of Medicine at the Stanford University School of Medicine, and former Dean of Education. Gardner was one of the first people to be publicly skeptical of Elizabeth Holmes, the founder of blood testing company Theranos, who was later found guilty of investor fraud.
The Dropout is an American true crime podcast hosted by Rebecca Jarvis that follows the story of Elizabeth Holmes, her defunct medical company Theranos, and the related federal criminal fraud trial, United States v. Elizabeth A. Holmes, et al. It was produced by ABC News, Taylor Dunn, Victoria Thompson, and Rebecca Jarvis. After the initial six episodes of the podcast aired in 2019, a two-hour 20/20 episode premiered in March 2019, following the popularity of the podcast. A second season of the podcast, titled, The Dropout: Elizabeth Holmes on Trial, debuted in 2022 and followed along with the criminal fraud federal trial of Holmes.
United States v. Elizabeth A. Holmes, et al., was a United States federal criminal fraud case against the founder of now-defunct corporation Theranos, Elizabeth Holmes, and its former president and COO, Ramesh Balwani. The case alleged that Holmes and Balwani perpetrated multi-million dollar wire-fraud schemes against investors and patients. Holmes and Balwani each had their own jury trial.